Concert Pharmaceuticals (CNCE) is developing innovative medicines with deuterium chemistry (heavy hydrogen) to address the needs of patients with chronic diseases. That's over my pay grade but the charts are interesting. Let's check it out.
More from Investing
It feels like these companies are casting a wide net, but it makes sense to file at the beginning of this mushroom mania.
Short selling is a powerful tool, but it is not just the inverse of going long and requires a very different mindset to do it effectively.
I believe the markets are headed lower - probably not in a straight line or as steep as the last few days, but in a saw tooth fashion lower.
It is premature to declare that the worst is over, but the intensity of the selling will go a long way toward helping a bottom to form.